SACRAMENTO — Gov. Gavin Newsom on Thursday announced a plan to offer $11 insulin pens through the state’s pharmaceutical venture.
Beginning Jan. 1, consumers can purchase a five-pack of pens for a suggested price of $55, according to the governor’s office. The packs will be available to California pharmacies for $45.
California is the first state in the nation to sell its own brand of generic prescription drugs as Newsom and other state leaders seek ways to drive down rising healthcare costs.
Insulin users without health insurance today can pay $400 for a small vial.
Newsom, in a statement Thursday, said that Californians shouldn’t “ration insulin or go into debt to stay alive.”
“California didn’t wait for the pharmaceutical industry to do the right thing — we took matters into our own hands,” Newsom said.
Officials hope the drug will lower costs across the board, not just for the consumers ultimately picking up the drug. Major drug companies have also cut prices on insulin, but critics contend those cost savings are passed on to other consumers.
Earlier this week, Newsom signed legislation, Senate Bill 40, capping insulin co-pays at $35 for the first time in California.
“This law ensures no family will be forced to choose between buying insulin and putting food on the table in California again,” the bill’s author, Sen. Scott Wiener (D-San Francisco), said in a statement.
Newsom, who vowed to be the “healthcare governor” during his campaign, in 2020 unveiled a proposal for California to make its own line of generic drugs.
Three years later, he announced a $50-million contract with the nonprofit generic drugmaker Civica to produce insulin under the state’s own label.
Earlier this year, the state began selling Naloxone, a medication that blocks the effects of opioids, at below market prices.
